X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (19809) 19809
Newspaper Article (1647) 1647
Publication (1621) 1621
Newsletter (754) 754
Book Review (126) 126
Book Chapter (66) 66
Dissertation (36) 36
Trade Publication Article (33) 33
Magazine Article (26) 26
Conference Proceeding (24) 24
Book / eBook (20) 20
Web Resource (8) 8
Reference (4) 4
Data Set (2) 2
Presentation (2) 2
Government Document (1) 1
Journal / eJournal (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
neuroblastoma (14180) 14180
humans (14127) 14127
index medicus (7445) 7445
oncology (6285) 6285
female (5718) 5718
male (5546) 5546
cancer (4409) 4409
child (4311) 4311
neuroblastoma - pathology (4268) 4268
child, preschool (4014) 4014
infant (3858) 3858
animals (3766) 3766
pediatrics (3468) 3468
tumors (3243) 3243
cell line, tumor (3150) 3150
apoptosis (2553) 2553
mice (2410) 2410
neuroblastoma - genetics (2392) 2392
prognosis (2383) 2383
adolescent (2301) 2301
research (2280) 2280
expression (2158) 2158
neuroblastoma - metabolism (2081) 2081
neurosciences (2054) 2054
chemotherapy (1997) 1997
adult (1924) 1924
children (1921) 1921
neuroblastoma - drug therapy (1878) 1878
proteins (1725) 1725
biochemistry & molecular biology (1628) 1628
gene expression (1615) 1615
cell biology (1534) 1534
analysis (1498) 1498
neuroblastoma - therapy (1484) 1484
surgery (1463) 1463
care and treatment (1390) 1390
metastasis (1336) 1336
hematology (1259) 1259
infant, newborn (1256) 1256
health aspects (1251) 1251
neuroblastoma - diagnosis (1251) 1251
tumor cells, cultured (1246) 1246
genetic aspects (1210) 1210
neoplasm staging (1182) 1182
middle aged (1159) 1159
diagnosis (1142) 1142
medicine (1075) 1075
cancer therapies (995) 995
cells (994) 994
mutation (976) 976
pathology (964) 964
article (961) 961
oxidative stress (960) 960
apoptosis - drug effects (956) 956
research article (952) 952
neuroblastoma - mortality (924) 924
treatment outcome (919) 919
retrospective studies (915) 915
medical research (890) 890
therapy (890) 890
kinases (884) 884
immunohistochemistry (882) 882
differentiation (869) 869
survival (864) 864
aged (856) 856
risk factors (851) 851
neuroblastoma-cells (838) 838
neuro-blastoma (837) 837
neuroblastoma - surgery (835) 835
patients (818) 818
gene expression regulation, neoplastic (810) 810
genes (802) 802
immunotherapy (794) 794
neurons (783) 783
development and progression (779) 779
pharmacology & pharmacy (779) 779
n-myc (776) 776
multidisciplinary sciences (770) 770
medical prognosis (763) 763
combined modality therapy (762) 762
brain (750) 750
genetics & heredity (750) 750
biology (749) 749
gene (743) 743
alzheimers-disease (736) 736
dose-response relationship, drug (736) 736
signal transduction (732) 732
antineoplastic combined chemotherapy protocols - therapeutic use (730) 730
medicine & public health (729) 729
studies (722) 722
neurology (716) 716
rats (715) 715
activation (712) 712
alzheimer's disease (707) 707
cell survival - drug effects (705) 705
time factors (699) 699
gene amplification (692) 692
cell line (688) 688
growth (684) 684
clinical neurology (683) 683
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (21644) 21644
Japanese (238) 238
German (184) 184
French (125) 125
Spanish (74) 74
Chinese (43) 43
Italian (36) 36
Russian (34) 34
Polish (30) 30
Korean (11) 11
Portuguese (10) 10
Dutch (8) 8
Czech (7) 7
Turkish (6) 6
Hebrew (2) 2
Norwegian (2) 2
Swedish (2) 2
Arabic (1) 1
Danish (1) 1
Hungarian (1) 1
Romanian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 12/2011, Volume 118, Issue 23, pp. 6050 - 6056
Journal Article
International Journal of Cancer, ISSN 0020-7136, 03/2015, Volume 136, Issue 5, pp. E252 - E261
Neuroblastoma is a childhood tumour with heterogeneous characteristics and children with metastatic disease often have a poor outcome. Here we describe the... 
neuroblastoma | orthotopic xenograft | patient‐derived xenograft | MYCN | bone marrow metastasis | neuroblastoma metastasis | Orthotopic xenograft | Neuroblastoma | Bone marrow metastasis | Neuroblastoma metastasis | Patient-derived xenograft | MODELS | ONCOLOGY | patient-derived xenograft | GROWTH | CELL-LINES | CANCER | Humans | Lung Neoplasms - metabolism | Child, Preschool | Infant | Male | Bone Marrow Neoplasms - genetics | Immunoenzyme Techniques | Heterografts | Lung Neoplasms - secondary | Female | Tumor Cells, Cultured | Liver Neoplasms - secondary | Child | Real-Time Polymerase Chain Reaction | Neuroblastoma - pathology | Lung Neoplasms - genetics | Liver Neoplasms - genetics | Neuroblastoma - genetics | RNA, Messenger - genetics | Genotype | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | Bone Marrow Neoplasms - secondary | Phenotype | Animals | Bone Marrow Neoplasms - metabolism | Liver Neoplasms - metabolism | Polymorphism, Single Nucleotide - genetics | Mice | Neuroblastoma - metabolism | Neuropeptide Y | Genetic markers | PET imaging | Genomics | Genetic aspects | Metastasis | Bone marrow | Patients | Cell adhesion & migration | Tumors | Cancer Cell Biology | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Molecular Therapy, ISSN 1525-0016, 09/2017, Volume 25, Issue 9, pp. 2214 - 2224
Targeting disialoganglioside (GD2) on neuroblastoma (NB) with T cells expressing a first-generation chimeric antigen receptor (CAR) was safe, but the cells had... 
neuroblastoma | GD2-CAR | immunotherapy | MEDICINE, RESEARCH & EXPERIMENTAL | NKT CELLS | ANTI-GD2 ANTIBODY | ANTITUMOR-ACTIVITY | THERAPY | IMMUNOTHERAPY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | GENETICS & HEREDITY | TUMOR-ASSOCIATED MACROPHAGES | SUPPRESSOR-CELLS | BLOCKADE | ANTIGEN RECEPTOR | STAGE 4 NEUROBLASTOMA | Antineoplastic Agents, Immunological - administration & dosage | Humans | Child, Preschool | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Neuroblastoma - mortality | Neuroblastoma - therapy | Lymphocyte Depletion | Molecular Targeted Therapy | Recombinant Fusion Proteins | Young Adult | T-Lymphocytes - metabolism | Neuroblastoma - immunology | Female | Child | Neuroblastoma - pathology | Cytokines - blood | Immunotherapy, Adoptive - adverse effects | Immunotherapy, Adoptive - methods | Receptors, Antigen, T-Cell - metabolism | Treatment Outcome | Combined Modality Therapy | Antineoplastic Agents, Immunological - adverse effects | Antineoplastic Agents, Immunological - therapeutic use | Adolescent | Lymphocyte Count | Myeloid Cells - metabolism | T-Lymphocytes - immunology | Receptors, Antigen, T-Cell - genetics | Transplantation Conditioning | Cohort Studies | Antigens | Lymphatic system | Myeloid cells | CD11b antigen | PD-1 protein | Lymphocytes T | Neuroblastoma | Metastasis | Patients | Fever | CD45 antigen | Blood | CD163 antigen | Cyclophosphamide | Pain | Fludarabine | Lymphocytes | Bone marrow | Antitumor activity | Movement disorders | Apoptosis | Neutropenia | Original
Journal Article
JAMA, ISSN 0098-7484, 03/2012, Volume 307, Issue 10, pp. 1062 - 1071
Journal Article
Journal of Labelled Compounds and Radiopharmaceuticals, ISSN 0362-4803, 12/2018, Volume 61, Issue 14, pp. 1069 - 1080
6‐[18F]Fluorodopamine ([18F]F‐DA) is taken into cells via the norepinephrine transporter (NET). Recent [18F]F‐DA positron emission tomography–computed... 
neuroblastoma | fluorine‐18 | PET | 6‐[18F]fluorodopamine | F‐DA | fluorine-18 | F]fluorodopamine | F-DA | CHEMISTRY, ANALYTICAL | CHEMISTRY, MEDICINAL | BIOCHEMICAL RESEARCH METHODS | HIGHLY EFFICIENT | AGENT | HEART | POSITRON-EMISSION-TOMOGRAPHY | METABOLISM | NOREPINEPHRINE TRANSPORTER | PET/CT | 6-[F-18]fluorodopamine | EXPRESSION
Journal Article
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, ISSN 0098-7484, 08/2019, Volume 322, Issue 8, pp. 746 - 755
Journal Article
Nature Reviews Cancer, ISSN 1474-175X, 06/2018, Volume 18, Issue 6, pp. 389 - 400
Journal Article